|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"heo jeong"
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: A sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng;Lee, Youn-Jae;Heo, Jeong;Ahn, Sang-Hoon;Lim, Young-Suk;Peng, Cheng-Yuan;Chang, Ting-Tsung;Torbeyns, Anne;Hughes, Eric;Bhore, Rafia;Noviello, Stephanie; JIA-HORNG KAO; Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: A pooled analysis
|
Kao, Jia-Horng;Jensen, Donald M.;Manns, Michael P.;Jacobson, Ira;Kumada, Hiromitsu;Toyota, Joji;Heo, Jeong;Yoffe, Boris;Sievert, William;Bessone, Fernando;Peng, Cheng-Yuan;Roberts, Stuart K.;Lee, Youn-Jae;Bhore, Rafia;Mendez, Patricia;Hughes, Eric;Noviello, Stephanie; JIA-HORNG KAO; Kao, Jia-Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng-Yuan; Roberts, Stuart K.; Lee, Youn-Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie |
| 國立成功大學 |
2016-10 |
Efficacy and Safety of Elbasvir/Grazoprevir in Treatment-Naive Subjects with Chronic HCV GT 1, GT 4 and GT 6 Infection (C-CORAL): A Phase III Randomized Multinational Clinical Trial
|
George, Jacob;Burnevich, Eduard Z.;Sheen, I-Shyan;Heo, Jeong;Van, Kinh Nguyen;Tanwandee, Tawesak;Cheng, Pin-Nan;Kim, Do Young;Tak, Won Young;Kizhlo, Svetlana N.;Liang, Li W.;Lindore, Pauline A.;Ginanni, Joy;Nguyen, Bach-Yen T.;Wahl, Janice;Barr, Eliav;Robertson, Michael;Talwani, Rohit |
| 國立成功大學 |
2016-10 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 國立臺灣大學 |
2016 |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
|
Kao, Jia-Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng-Yuan; Roberts, Stuart K.; Lee, Youn-Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2016 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie; 高嘉宏 |
| 國立成功大學 |
2014-11-01 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
Manns, Michael; Pol, Stanislas; Jacobson, Ira M.; Marcellin, Patrick; Gordon, Stuart C.; Peng, Cheng-Yuan; Chang, Ting-Tsung; Everson, Gregory T.; Heo, Jeong; Gerken, Guido; Yoffe, Boris; Towner, William J.; Bourliere, Marc; Metivier, Sophie; Chu, Chi-Jen; Sievert, William; Bronowicki, Jean-Pierre; Thabut, Dominique; Lee, Youn-Jae; Kao, Jia-Horng; McPhee, Fiona; Kopit, Justin; Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie |
| 國立臺灣大學 |
2014 |
Safety and efficacy outcomes of all-oral daclatasvir-containing regimens in patients with or without cirrhosis in phase 2 and 3 studies
|
Jensen, Donald M.; Jacobson, Ira M.; Kumada, Hiromitsu; Toyota, Joji; Sulkowski, Mark S.; Manns, Michael P.; Kao, Jia-Horng; Heo, Jeong; Yin, Philip; Mendez, Patricia; Hughes, Eric A.; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
